Bianca Lewis

Bianca Lewis’ broad transactional and regulatory practice focuses on matters at the intersection of technology, media, advertising and data privacy, with a special interest in life sciences. As part of her broad practice, she advises clients on a wide array of complex privacy, data security and FDA and health care regulatory issues.

Regularly working with clients in the life sciences, consumer products, entertainment and media and software and technology industries, Bianca has experience drafting and negotiating commercial agreements for clients in the real estate, entertainment and media industries, clinical trial agreements for pharmaceutical and biotechnology companies seeking FDA approval of therapeutic products, and advising multi-national pharmaceutical company on HIPAA compliance training, as well as agreements involving mergers and acquisitions in life sciences, employment matters and asset purchases, among others. Bianca regularly advises clients on issues pertaining to U.S. and global data privacy laws and regulations, including the GDPR, HIPAA, CCPA and CPRA.

As part of her Mergers & Acquisitions practice, she assists clients with understanding the privacy and FDA regulatory considerations for various acquisitions. She also advises clients on FDA regulatory pathway strategies and FDA compliance issues for mergers and acquisitions deals, public offerings and commercial disputes for clients in the biopharmaceutical, medical device and tobacco product industries. In addition, Bianca counsels clients on corporate governance, business entity formation, corporate policies, as well as assisting with debt capital market transactions, including convertible note offerings.